Clorox Co. (0I0J)
London Exchange · UK · prices in USD · close of 23 Oct 2026
Key indicators
| Last close | USD 86.27 |
|---|---|
| 52-week range | 79.11 – 129.00 |
| Return, 1 month / 3 months | +0.9% / −6.6% |
| Return, 1 year / 3 years | −23.7% / −21.5% |
| Trend | Below its 200-day average |
| RSI (14) | 50 |
| Volatility (1 year) | 31.7% |
| Worst drawdown (1 year) | -36.1% |
| Average daily value traded | 0.22M USD |
| Dividend yield | 4.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Clorox makes household cleaning and consumer products sold mainly through grocery stores, mass retailers and other shops. Its range includes bleach and other cleaning supplies, drain and clog products, cat litter, charcoal, and food storage bags and wraps. The company is based in Oakland, California, in the United States, and its products reach households through retail channels in the Americas and other markets.
On this site Clorox Co. appears as a stock on the London Exchange (UK), code 0I0J, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Clorox Co. (0I0J) trades on the London Exchange in UK. It last closed at USD 86.27 on 23 October 2026.
Its price-based Market X-Ray is 38 out of 100 (a weak price profile), ranking 2,735 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 23.7% and over the last three months it fell 6.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 24 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -12.8% | ||
| From 52-week high | -32.7% | ||
| Momentum | 27 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -6.6% | ||
| 6-month return | -11.0% | ||
| 12-month return, skipping the last month | -24.4% | ||
| Stability (higher is calmer) | 48 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 31.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -36.1% | ||
| Liquidity | 38 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.22M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 77 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 4.3% | ||
| Years with dividends | 6 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.2% |
|---|---|
| 1 month | +0.9% |
| 3 months | −6.6% |
| 6 months | −11.0% |
| 1 year | −23.7% |
| 3 years | −21.5% |
| 5 years | −36.3% |
Signals
| 50-day / 200-day average | 90.61 / 98.95 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.95 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 Aug 2026 | USD 1.2500 |
| 21 Apr 2026 | USD 1.2400 |
| 27 Jan 2026 | USD 1.2400 |
| 21 Oct 2025 | USD 1.2400 |
| 13 Aug 2025 | USD 1.2400 |
| 22 Apr 2025 | USD 1.2200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.